| Assessment of neovascular armd activity with a new clinical activity scoring | Şengül ÖZDEK | 159–164 |
| Diagnosis, treatment, and visual outcome in patients with retinal vasculitis | Aynacı Burcu KAHRAMAN,Aydın Yonca AKOVA,İmren AKKOYUN | 165–170 |
| Efficacy of intravitreal bevacizumab injection for the treatment of macular edema secondary to retinal vein occlusion | Volkan EKEN,Figen BATIOĞLU,Emin ÖZMERT,Rahmi DUMAN | 171–175 |
| Clinical course in angiod streaks patients | Mehmet TETİKOĞLU,Muzaffer ÖZTÜRK,Osman ERDOKUR,Mustafa Nuri ELÇİOĞLU | 176–179 |
| Outcomes of primary pars plana vitrectomy in patients with rhegmatogen and tractional retinal detachment | ERDİNÇ AYDIN,Hüseyin YARDIM | 180–184 |
| Clinical and surgical features of eyes with retained lens fragments during cataract surgery and treatment results at 6 months | HÜRKAN KERİMOĞLU,Ümit KAMIŞ,Mehmet ADAM,Ahmet ÖZKAĞNICI,Kemal GÜNDÜZ,Süleyman OKUTAN | 185–191 |
| Vitreoretinal surgical outcomes for posterior segment ıntraocular foreign bodies | Yasemin ÖZDAMAR,Coşar BATMAN,Nilüfer BERKER,Hakan TIRHIŞ,Solmaz ÖZALP,Özlem ASLAN,JALE KARAKAYA KARABULUT,Seyhan ÖZKAN | 192–196 |
| Intravitreal bevacizumab therapy in patients with polypoidal choroidal vasculopathy | Fevzi ŞENTÜRK,Serra Arf KARAÇORLU,Hakan ÖZDEMİR,Murat KARAÇORLU | 197–201 |
| Effect of duration of macular detachment on early visual acuity results in macula of rhegmatogenous retinal detachments | HÜRKAN KERİMOĞLU,Mehmet ADAM,Meydan TURAN,Banu ÖZTÜRK,Hamiyet PEKEL,Süleyman OKUDAN | 202–205 |
| Alterations in corneal thickness, lens thickness, and anterior chamber depth in the early postoperative period after vitreoretinal surgery | Uğur GÜRLEVİK,Yasemin ÖZDAMAR,Hakan TIRHIŞ,JALE KARAKAYA KARABULUT,Orhan ZİLELİOĞLU | 206–209 |
| Retrobulber nörit tedavisi için sistemik steroid kullanan hastada gelişen iki tarafı santral seröz koryoretinopati | Bahri AYDIN,Şengül ÖZDEK,Onur KONUK,Gökhan GÜRELİK,Fikret AKATA,Berati HASANREİSOĞLU | 210–212 |